The Pediatric Cancer Program at UI Hospitals and Clinics provides
state-of-the-art medical care, rehabilitation, research, and
teaching. The program uses a unique outreach network to
incorporate primary, secondary, and tertiary care into a
regional multidisciplinary team. This network allows
patients in rural areas to receive most of their medical
care in their own community, irrespective of treatment
protocol complexity, or geographical location.
Following referral to University Hospitals, each patient
is assigned a primary physician and nurse who supervise and
coordinate the multidisciplinary team. They communicate
with, and educate, patients and parents. They also finalize
treatment plans and communicate with the referring
physician.
Services
To simplify protocol complexity, a data managment team
provides computerized, patient specific and date specific,
treatment forms. These forms provide a detailed list of
drugs and procedures, related potential toxicities, dosage
and dose modifications, that allow oncologists and
nononcologists to follow protocols accurately and
efficiently. The forms serve as a standard method of
communication and medical documentation, having been
approved as official medical records. Computer forms, along
with a 24-hour hot line for consultation, and extensive
family counseling and education, have resulted in a very
successful partnership between University Hospitals and over
200 referring physicians. The program was the first in the
nation to have 100 percent protocol compliance in 1991.
To facilitate social adjustment and acceptance, a school
reentry program was initiated recently at no cost to the
patient, whereby an oncology nurse performs an on-site
conference with the school nurse, principal, teachers, and
classmates.
The pediatric cancer program is a full member participant
in the Children's Cancer Group, The National Wilms' Tumor
Study, and The Intergroup Rhabdomyosarcoma Study. Through a
combination of local and national protocols, all pediatric
cancer patients receive state-of-the-art care. Frequently
seen pediatric cancers are treated according to national or
local protocols. Patients with rare tumors are treated
according to patient specific protocols. Besides standard
chemotherapeutic agents, surgery, radiation therapy, and
supportive care, treatment modalities include
investigational chemotherapeutic agents, immunotherapy,
biotherapy, chemoembolization, brachytherapy, intraoperative
radiation therapy, and cryotherapy. The Pediatric Bone
Marrow Transplant Program offers several modalities for
transplantation-in addition to the classical allogeneic and
autologous transplants, a unique method of T-cell depletion
allows patients to receive a transplant from matched
unrelated donors, and partially matched or mismatched
related donors, widening significantly the range of
transplant possibilities.
|
|